Overview

Preliminary Evaluation of Safety and Efficacy by [14C] AC0010 Trail and Subsequent AC0010 Treatment

Status:
Completed
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate safety and efficacy of male Patients With Advanced NSCLC who participant in [14C] AC0010 ADME.
Phase:
Phase 1
Details
Lead Sponsor:
Hangzhou ACEA Pharmaceutical Research Co., Ltd.
Hangzhou ACEA Pharmaceutical Research Co.,Ltd.
Treatments:
Abivertinib